Literature DB >> 24648472

PD-1 deletion restores susceptibility to experimental autoimmune encephalomyelitis in miR-155-deficient mice.

Jinyu Zhang1, Michel Y Braun2.   

Abstract

MiR-155 (-/-) mice are highly resistant to experimental autoimmune encephalomyelitis (EAE), while Pdcd1 (-/-) mice develop a more severe form of the disease. To determine the conflicting roles of these two molecules in the disease, we generated miR-155 (-/-) Pdcd1 (-/-) double knockout (DKO) mice. We found that ablation of programmed cell death protein 1 (PD-1) expression in miR-155-deficient mice restored the susceptibility to EAE. The increased severity of the disease in DKO mice was accompanied by an enhanced T-cell infiltration into the brain as well as an increased production of pro-inflammatory cytokines IFN-γ and IL-17. Furthermore, the major contribution of the DKO to EAE was T-cell intrinsic since adoptive transfer of CD4(+) T cells from DKO donors promoted the disease in lymphopenic recipients. These results define PD-1 deficiency in miR-155 (-/-) mice as a promoting factor of autoimmune inflammation by increasing antigen-driven T-cell expansion and infiltration. © The Japanese Society for Immunology. 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IFN-γ; IL-17; autoimmunity; inflammation; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24648472     DOI: 10.1093/intimm/dxu043

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Authors:  Nina C Zitzer; Katiri Snyder; Xiamoei Meng; Patricia A Taylor; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Ramiro Garzon; Parvathi Ranganathan
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

2.  Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.

Authors:  L C M Arruda; J C C Lorenzi; A P A Sousa; D L Zanette; P V B Palma; R A Panepucci; D S Brum; A A Barreira; D T Covas; B P Simões; W A Silva; M C Oliveira; K C R Malmegrim
Journal:  Bone Marrow Transplant       Date:  2014-12-08       Impact factor: 5.483

Review 3.  DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging.

Authors:  Fabiola Olivieri; Maria Cristina Albertini; Monia Orciani; Artan Ceka; Monica Cricca; Antonio Domenico Procopio; Massimiliano Bonafè
Journal:  Oncotarget       Date:  2015-11-03

4.  Key questions about the checkpoint blockade-are microRNAs an answer?

Authors:  Mihnea Dragomir; Baoqing Chen; Xiao Fu; George A Calin
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

Review 5.  Role of the PD-1/PD-L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions.

Authors:  Yan Mi; Jinming Han; Jie Zhu; Tao Jin
Journal:  Mol Neurobiol       Date:  2021-09-03       Impact factor: 5.590

6.  Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.

Authors:  Jinyu Zhang; Michel Y Braun
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

7.  PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration.

Authors:  J Obst; R Mancuso; E Simon; D Gomez-Nicola
Journal:  Brain Behav Immun       Date:  2018-08-04       Impact factor: 7.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.